Tourmaline Bio Announces Proposed Public Offering Of Common Stock; No Size Or Amount Disclosed
Tourmaline Bio, Inc. ("Tourmaline") (NASDAQ:TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients with life-altering immune and inflammatory